Imidazolium salts, intermediates thereto and their use
申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0131302A2
公开(公告)日:1985-01-16
The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.
The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.